Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 4/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 1/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.55 |
| ▸ | BRD4 | O60885 | 4/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | COMT | P21964 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2519345 | 0.83 | KDM4E (0.72) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL2582932 | 0.82 | PAX8 (0.58) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL5594514 | 0.81 | KDM4E (0.64) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL114710 | 0.78 | KDM4E (0.74) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL27911013 | 0.78 | KDM4E (0.74) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL9177673 | 0.77 | KDM4E (0.79) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL31237495 | 0.77 | KDM4E (0.79) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL1782934 | 0.77 | KDM4E (1.00) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL30159468 | 0.77 | KDM4E (1.00) | KDM4EL3MBTL1NPC1HTTRAB9A | |
| SCHEMBL30122537 | 0.77 | MAOA (0.61) | KDM4EL3MBTL1NPC1HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382193-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | Biopharmed (FR) | 2011-11-02 | — | — | EP | disclosed |
| US-20110251238-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | BIOPHARMED (FR) | 2011-10-13 | — | — | US | disclosed |
| WO-2010073235-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | BIOPHARMED (FR) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251238-A1 | PPAR AGONIST COMPOSITIONS AND METHODS OF USE | PPARA, PPARG, PPARD | KDM4E 4239/4885L3MBTL1 4433/4885NPC1 675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.